KRT18 and metabolic dysfunction-associated steatohepatitis: In terms of diagnostic efficacy for NASH, CK-18 shows moderate accuracy with specificity of 80% and the area under the receiver operating characteristics curve (AUROC) of 0.83, however, its sensitivity is low at 60% [7].